Balance Sheet Components (Tables)

3 Months Ended

Mar. 31, 2025

Balance Sheet Related Disclosures [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):


		March 31, 2025				December 31, 2024
Prepaid clinical trial		$	1,832			$	1,112
Prepaid research and development			926				841
Prepaid insurance			232				249
Deferred offering costs			140				135
Other			536				308
Total prepaid expenses and other current assets		$	3,666			$	2,645

Schedule of Property Plant and Equipment Net

Property, plant and equipment, net consisted of the following (in thousands):


		March 31, 2025				December 31, 2024
Leasehold improvements		$	2,117			$	2,117
Laboratory equipment			3,163				3,130
Computer equipment			674				707
Furniture and fixtures			853				864
Construction in progress			4,247				4,251
			11,054				11,069
Accumulated depreciation			(3,818	)			(3,584	)
Property, plant and equipment, net		$	7,236			$	7,485

Schedule of Accrued Expense and Other Current Labilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


		March 31, 2025				December 31, 2024
Accrued compensation		$	2,510			$	5,242
Accrued clinical trial			2,207				1,907
Lease liabilities, current portion			1,808				1,877
Accrued research and development			1,518				1,714
Accrued professional and consulting fees			1,576				725
Warrant liability			336				438
Accrued property, plant and equipment			—				207
Other			806				752
Total accrued expenses and other current liabilities		$	10,761			$	12,862